tiprankstipranks
Bristol Myers CEO says new drug Cobenfy effective in schizophrenia, CNBC reports
PremiumThe FlyBristol Myers CEO says new drug Cobenfy effective in schizophrenia, CNBC reports
3d ago
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
Premium
The Fly
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
4d ago
Bristol-Myers Squibb Unveils Strategic Growth Plan
Premium
Company Announcements
Bristol-Myers Squibb Unveils Strategic Growth Plan
5d ago
PFE, BMY, SNY, and Others Are Set to Raise Prices on 250 Drugs
PremiumMarket NewsPFE, BMY, SNY, and Others Are Set to Raise Prices on 250 Drugs
18d ago
Bristol-Myers Squibb’s Patent Expansion Plan May Run into Regulator Trouble
Premium
Market News
Bristol-Myers Squibb’s Patent Expansion Plan May Run into Regulator Trouble
19d ago
Halozyme reports FDA approval for Opdivo co-formulated with Enhanze
Premium
The Fly
Halozyme reports FDA approval for Opdivo co-formulated with Enhanze
19d ago
Bristol Myers receives EC approval for Opdivo plus Yervoy
PremiumThe FlyBristol Myers receives EC approval for Opdivo plus Yervoy
26d ago
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
28d ago
Bristol Myers enters $100M PyroGlu-Ass license agreement with BioArctic
Premium
The Fly
Bristol Myers enters $100M PyroGlu-Ass license agreement with BioArctic
30d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100